The next milestone in clinical trial of a measurement system developed to diagnose NAFLD

Nina Györfi, A. Vereczkei, Z. Karádi, Károly Kalmár Nagy, Zoltán Vízvári, Zoltan Sári, P. Odry, Adrián Róbert Gál, Attila Tóth
{"title":"The next milestone in clinical trial of a measurement system developed to diagnose NAFLD","authors":"Nina Györfi, A. Vereczkei, Z. Karádi, Károly Kalmár Nagy, Zoltán Vízvári, Zoltan Sári, P. Odry, Adrián Róbert Gál, Attila Tóth","doi":"10.1109/CINTI53070.2021.9668383","DOIUrl":null,"url":null,"abstract":"Our publication presents the next important milestone in development of method aimed at the nondestructive diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD). In clinical trials, a specific group of patients (with liver and other carcinomas) were studied. In their case, liver histological examinations are always carried out, which has given us the opportunity to compare bioimpedance spectrum (BIS) data with biopsy results. In our publication, we present the relevant measurement methodology after that we highlight some typical examples that describe the most common pathologies and their associated BIS origins.","PeriodicalId":340545,"journal":{"name":"2021 IEEE 21st International Symposium on Computational Intelligence and Informatics (CINTI)","volume":"31 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2021 IEEE 21st International Symposium on Computational Intelligence and Informatics (CINTI)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/CINTI53070.2021.9668383","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Our publication presents the next important milestone in development of method aimed at the nondestructive diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD). In clinical trials, a specific group of patients (with liver and other carcinomas) were studied. In their case, liver histological examinations are always carried out, which has given us the opportunity to compare bioimpedance spectrum (BIS) data with biopsy results. In our publication, we present the relevant measurement methodology after that we highlight some typical examples that describe the most common pathologies and their associated BIS origins.
用于诊断NAFLD的测量系统临床试验的下一个里程碑
我们的出版物提出了非酒精性脂肪性肝病(NAFLD)无损诊断方法发展的下一个重要里程碑。在临床试验中,研究了一组特定的患者(患有肝癌和其他癌症)。在他们的病例中,总是进行肝脏组织学检查,这使我们有机会将生物阻抗谱(BIS)数据与活检结果进行比较。在我们的出版物中,我们介绍了相关的测量方法,然后我们强调了一些描述最常见病理及其相关BIS起源的典型例子。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信